氨基末端腦鈉肽前體對嬰兒期左向右分流型先天性心臟病心功能評估的臨床應(yīng)用價(jià)值
[Abstract]:Objective to investigate the changes of plasma amino-terminal brain natriuretic peptide (N-Terminal pro-Brain Natriuretic Peptide,NT-pro BNP) levels in infants with left to right shunt congenital heart disease (Congenital Heart Disease,CHD) complicated with heart failure (Heart Failure,HF). The relationship between plasma NT-pro BNP and modified Ross score was analyzed by evaluating the clinical cardiac function of these children with HF, and the operating characteristic (Receiver Operating Characteristic,ROC curve was plotted. To find out the rapid detection method of left to right shunt type CHD combined with HF in infancy, to find out the diagnostic truncation value of plasma NT-Pro BNP in children with HF with different cardiac function grades, and to quantify the HF grade, which is when left to right shunt type CHD is combined with HF in infancy. To provide more objective, simple and practical diagnostic criteria for HF. Methods from January 2015 to June 2016, 54 patients with left to right shunt CHD, including atrial septal defect (Atrial Septal Defect,ASD), were treated in Department of Cardiology, Department of Pediatrics, Anhui Medical University. Ventricular septal defect (Ventricular Septal Defect,VSD), patent ductus arteriosus (Patent Ductus Arteriosus,PDA). The average age was 144 鹵93 days, including 32 males and 22 females. The control group consisted of 12 children with normal renal function, including 8 males and 4 females, aged from one month to one year, with an average age of 212 鹵127days. According to the modified Ross scoring method, the patients in the study group were graded with HF, including 13 cases without HF, 15 cases with mild HF, 13 cases with moderate HF and 13 cases with severe HF. The peripheral venous blood was taken from all the children in the study group and the control group after admission. The cobas H232 rapid heart failure diagnostic instrument and the corresponding Roche CARDIAC test strip were used to detect the results. The test results can be measured in 812 minutes. Results there was a positive correlation between the plasma NT-pro BNP level and the modified Ross score in children with CHD, which increased with the increase of the modified Ross score (P 0.05). Compared with the control group, the level of plasma NT-pro BNP in patients with left to right shunt type CHD was significantly increased (P0.05), and plasma NT-pro BNP was significantly different among different HF grades (F59.68%, P0.05). There was significant difference in plasma NT-pro BNP before and after treatment in children with HF of different degree (P0.05). By drawing ROC curve, the diagnostic truncation value of plasma NT-pro BNP in patients with left to right shunt type CHD combined with HF was 286.50pg/m L, and that of mild HF was 635.50pg/m L. In the diagnosis of moderate HF, the truncation value was 1680.5pg/m L, and the truncation value of severe HF was 3863.00pg/m L. Conclusion Plasma NT-pro BNP can sensitively reflect the severity of HF and has a positive correlation with the modified Ross score. The results show that NT-pro BNP286.50pg/m L can be used as the diagnostic truncation value of left to right shunt type CHD in infancy, and the truncation value of mild HF is 635.5pg/m L. The truncation value of moderate HF and severe HF was 1680.5pg/m L and 3863pg/m L, respectively. There were significant differences between different heart function groups before and after treatment, which could be used as an important monitoring method for evaluating the therapeutic effect of these children with HF.
【學(xué)位授予單位】:安徽醫(yī)科大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2017
【分類號】:R725.4
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 金文青;邱潮林;陳宇嵐;;氨基末端腦鈉肽前體檢測在診斷老年慢性支氣管炎伴心力衰竭中的作用[J];上海醫(yī)藥;2016年08期
2 何軍;;動態(tài)監(jiān)測NT-proBNP指導(dǎo)慢性心力衰竭患者治療的臨床意義[J];醫(yī)學(xué)綜述;2015年22期
3 陸桂寧;林春旺;曾祥林;江少虎;;0~7歲兒童年齡分層后血漿氨基末端B型利鈉肽前體診斷心力衰竭的閾值[J];廣東醫(yī)學(xué);2015年10期
4 林春旺;翁曉陽;曾祥林;孟秀會;江少虎;歐陽輝;;小兒先天性心臟病術(shù)前血漿氨基末端B型利鈉肽前體檢測及慢性心力衰竭診斷截?cái)帱c(diǎn)探討[J];中國婦幼保健;2013年22期
5 江少虎;林春旺;曾祥林;吳彤;汪江萍;張金鳳;歐陽輝;謝純平;;血漿N末端B型利鈉肽前體檢測在心力衰竭患兒的臨床應(yīng)用[J];中國小兒急救醫(yī)學(xué);2012年06期
6 何衛(wèi)華;潘海清;王世昌;;NT-proBNP動態(tài)變化對充血性心力衰竭患者近期預(yù)后的評估價(jià)值[J];安徽醫(yī)學(xué);2012年11期
7 鄒宗武;;血漿腦鈉肽前體與慢性心衰的相關(guān)性分析[J];安徽醫(yī)學(xué);2012年11期
8 林春旺;曾祥林;吳彤;江少虎;汪江萍;張金鳳;歐陽輝;;心力衰竭患兒血漿氨基末端B型利鈉肽前體檢測的臨床意義[J];實(shí)用兒科臨床雜志;2012年13期
9 李雄;陽明玉;秦靜廷;張立飛;林毅;王丹;王長英;;先天性心臟病并心力衰竭患兒血漿氨基末端腦利鈉肽前體水平變化的臨床意義[J];實(shí)用兒科臨床雜志;2012年01期
10 陳樹寶;李萬鎮(zhèn);馬沛然;錢永如;寧壽葆;;小兒心力衰竭診斷與治療建議[J];中華兒科雜志;2006年10期
,本文編號:2365135
本文鏈接:http://sikaile.net/shoufeilunwen/mpalunwen/2365135.html